These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6107085)

  • 1. Effects of propranolol on the biochemical modifications induced by a beta-adrenergic drug in ischemic hearts.
    Andrieu JL; Lièvre M; Chah QT; Faucon G
    Biochem Pharmacol; 1980 Oct; 29(19):2687-90. PubMed ID: 6107085
    [No Abstract]   [Full Text] [Related]  

  • 2. Increase of myocardial pH by 1- and d-propranolol during ischemia of the heart in dogs.
    Abiko Y; Sakai K
    Eur J Pharmacol; 1980 Jun; 64(4):239-47. PubMed ID: 6248350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of isoproterenol on the metabolism of normal and ischemic heart.
    Andrieu JL; Vial C; Font B; Goldschmidt D; Ollagnier M; Faucon G
    Arch Int Pharmacodyn Ther; 1980 Apr; 244(2):255-69. PubMed ID: 7406584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of propranolol on accumulation of NEFA in the ischemic perfused rat heart.
    Nakamura K; Ichihara K; Abiko Y
    Eur J Pharmacol; 1989 Jan; 160(1):61-9. PubMed ID: 2714364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propranolol inhibits accumulation of non-esterified fatty acids in the ischemic dog heart.
    Miura I; Hashizume H; Abiko Y
    Eur J Pharmacol; 1988 Aug; 152(3):281-8. PubMed ID: 3220107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propranolol and experimental myocardial infarction: substrate effects.
    Opie LH; Thomas M
    Postgrad Med J; 1976; 52 Suppl 4():124-32. PubMed ID: 787952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of myocardial metabolic effects of in subendocardial and subepicardial layers ischaemia and beta-adrenergic stimulation (author's transl)].
    Al Makdessi S; Andrieu JL; Tuduri A; Timour Chah Q; Faucon G
    J Pharmacol; 1982; 13(2):265-75. PubMed ID: 6124657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial metabolism and dynamics after practolol during light halothane anaesthesia.
    Merin RG
    Br J Anaesth; 1972 May; 44(5):437-45. PubMed ID: 4402950
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on experimental coronary insufficiency. II. Effects of beta-adrenergic blocking agent (propranolol) on metabolic response to adrenaline and noradrenaline in dogs with coronary constriction.
    Iimura O; Wakabayashi C; Kobayashi T; Shoji T; Yoshida S; Miyahara M
    Recent Adv Stud Cardiac Struct Metab; 1976 May 26-29; 12():543-7. PubMed ID: 1032009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of norepinephrine on myocardial metabolism before and after beta receptor blockade.
    Glaviano VV; Masters TN
    Eur J Pharmacol; 1969 Aug; 7(2):135-42. PubMed ID: 5345990
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of propranolol on the circulatory changes and mobilization of free fatty acids caused by isoproterenol.
    Nakano J; Kusakari T; Berry JL
    Arch Int Pharmacodyn Ther; 1966 Nov; 164(1):120-7. PubMed ID: 5972306
    [No Abstract]   [Full Text] [Related]  

  • 12. The influence of myocardial metabolism on ischemic damage.
    Oliver MF
    Circulation; 1976 Mar; 53(3 Suppl):I168-70. PubMed ID: 45824
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolic effects of inosine and uridine in rabbit hearts and rat skeletal muscles.
    Kypson J; Hait G
    Biochem Pharmacol; 1977 Sep; 26(17):1585-91. PubMed ID: 901578
    [No Abstract]   [Full Text] [Related]  

  • 14. Ischemic cardiac metabolism in man.
    Apstein C; Keller N; Kline SA; Tarjan E; Carlson RG; Brachfield N
    Bull N Y Acad Med; 1971 Oct; 47(10):1223. PubMed ID: 5286456
    [No Abstract]   [Full Text] [Related]  

  • 15. Myocardial non-esterified fatty acids during normoxia and ischemia in Langendorff and working rat hearts.
    Nasa Y; Ichihara K; Abiko Y
    Jpn J Pharmacol; 1990 May; 53(1):129-33. PubMed ID: 2112658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of endo- and epicardial glycogenolysis by propranolol in ischemic hearts.
    Ichihara K; Abiko Y
    Am J Physiol; 1977 Apr; 232(4):H349-53. PubMed ID: 851197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta adrenergic blockade. Hemodynamics and myocardial energy metabolism in patients with ischemic heart disease.
    Lewis CM; Brink AJ
    Am J Cardiol; 1968 Jun; 21(6):846-59. PubMed ID: 5678218
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of ouabain and propranolol on the mechanical function and metabolism of the ischemic myocardium].
    da Luz PL; Forrester JS; Wyatt HL
    Arq Bras Cardiol; 1983 Mar; 40(3):155-61. PubMed ID: 6651553
    [No Abstract]   [Full Text] [Related]  

  • 19. Nitroglycerin and propranolol on myocardial O2 consumption during myocardial ischemia.
    Daniell HB
    Eur J Pharmacol; 1977 Mar; 42(1):79-84. PubMed ID: 403076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of propranolol on regional oxygen balance in the ischemic canine myocardium].
    Sakata S; Toriumi S; Takata K; Saito T; Arase T
    Masui; 1987 Jan; 36(1):39-45. PubMed ID: 3560425
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.